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CytotoxicityThe crude extracts of Dietes bicolor leaves, ﬂowers and rhizomes were subjected to comparative antimicrobial
screening against two Gram-positive, two Gram-negative bacteria and four fungal strains using the agar well diffu-
sion method. The minimum inhibitory concentrations (MIC) of the tested extracts were also determined. Further-
more, the cytotoxic activity was evaluated. D. bicolor extracts generally demonstrated notable broad spectrum
antimicrobial activities (MIC values≤ 500 μg/mL) against all tested pathogens.D. bicolor leaf extract showed potent
broad spectrum antimicrobial activity with MIC values ranging between 0.24 and 31.25 μg/mL against all tested
pathogens.Moreover, theﬂowers extract exhibitedpromising antimicrobial activities, displayingMIC values ranging
between1.95 and 125 μg/mL against the tested bacteria and fungi. However, the rhizomes extract showedmoderate
antimicrobial activity with MIC values ranging between 31.25 and 500 μg/mL. Despite the potent antimicrobial ac-
tivity of D. bicolor extracts, they were ineffective as cytotoxic agents against nine tested cancer cell lines, displaying
50% inhibitory concentration (IC50) values above 100 μg/mL. The reported potent antimicrobial activity along with
the lack of measurable cytotoxic activity indicated that the antimicrobial activity of D. bicolor crude extracts is me-
diated through a mechanism other than cytotoxicity. These results suggest that D. bicolor can act as a potential
source for natural antibacterial and antifungal agents with a good safety proﬁle at a preliminary level.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Infectious diseases are still a leading cause of morbidity and mortal-
ityworldwide, despite the great progress inmedical technology and sci-
entiﬁc knowledge (Moellering et al., 2007). Historically, natural
products and their derivatives have been an invaluable source of thera-
peutic agents. In vitro and in vivo antimicrobial assays have effectively
served as reliablemethods to detect several classes of secondarymetab-
oliteswith potent antimicrobial activity such as penicillins, tetracyclines
and glycopeptides (Koehn and Carter, 2005; Silver and Bostian, 1990).
However, resistance to antibiotics is intensifying, thus searching for
new antimicrobial agents is an urgent unmet goal (Tekwu et al.,
2012). Besides synthetic small molecules, natural products are still con-
sidered as the major sources of innovative new therapeutic entities
targeting a plethora of ailments including infectious diseases (Clardy
and Walsh, 2004). The screening for new antimicrobials often involves
plant secondarymetabolites exhibiting pharmacological activity against; IC50, 50% inhibitory concentra-
zoliumbromide.
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hts reserved.pathogens. Among the modern antifungals used nowadays, about 40%
are of natural origin (Freiesleben and Jäger, 2014).
According to the WHO, 70–95% of the population in developing
countries depend mainly on herbal medicines for their health care
(WHO, 2011). Medicinal plants are freely available, less expensive,
and their use is based on expertise and extensive knowledge among
local communities (Mabona and Van Vuuren, 2013; Shai et al., 2008).
Medicinal plants have been commonly used in traditional medicine
for the treatment of infectious diseases. Antimicrobials from plant
sources may exert their activity through mechanisms different from
those of currently used synthetic drugs, thus they can signiﬁcantly
help in the treatment of resistant microbial strains. Examples of micro-
organisms that have gained resistance to antimicrobials include Pseudo-
monas aeruginosa, Escherichia coli, Salmonella typhi, Salmonella
enteritidis, Shigella dysenteriae, Streptococcus faecalis, Staphylococcus au-
reus and Candida albicans (Barbour et al., 2004).
Dietes is amember of family Iridaceae, subfamily Iridoideae (Goldblatt,
1981). It is closely related to both genera Iris andMoraea. The genusDietes
comprises of six species; ﬁve are native to South Africa and one (Dietes
robinsoniana) is restricted to Lord Howe Island between Australia and
New Zealand. The ﬁve African species include Dietes bicolor, Dietes
iridioides, Dietes ﬂavida, Dietes grandiﬂora and Dietes butcheriana
(Goldblatt, 1981). D. bicolor (Steud.) Sweet ex Klatt, commonly known
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perennial plant with sword-like leaves and Iris-like ﬂowers that are
white to creamy yellow in color and have three dark spots each
surrounded by an orange outline (Pooley, 1999; Rudall, 1983). The
genus name “Dietes” is derived from the Greek word “dis”which means
twice and from the Latin “etum” which means a plant association for its
close relationship to both Iris and Moraea. The species name “bicolor”
means two-colored (Cunliff and Teicher, 2005).
Family Iridaceae is widely used in traditional medicine to treat ﬂu,
cold, toothache, malaria, and bruise (Lin et al., 2002). Extracts or active
principles obtained from members of this family have shown a wide
range of biological activities including antibacterial, antiprotozoal, anti-
viral, antioxidant, antinociceptive, anti-inﬂammatory cytotoxic, and im-
munomodulatory activities (Lucena et al., 2007; Rahman et al., 2003).
The major secondary metabolites isolated from members of Iridaceae
include isoﬂavonoids, ﬂavonoids, triterpenoids, naphthoquinones, an-
thraquinones, naphthalene derivatives, xanthones and simple phenolics
(Kukula-Koch et al., 2013; Mahabusarakam et al., 2010).
Many plants are used in traditionalmedicine in the formof crude ex-
tracts or infusions to treat various infections without scientiﬁc evidence
(Noumi and Yomi, 2001). Scientiﬁc evidence formedicinal claims repre-
sents themost important limiting factor for indigenous herbal products
development (VanWyk, 2011). Infusions of the inner part ofD. iridioides
rhizomes are used by traditional healers in South Africa for the treat-
ment of diarrhea and dysentery (Pujol, 1990). Despite the traditional
use of Dietes for the treatment of diarrhea and dysentery, there are no
scientiﬁc reports studying this effect. We could not even ﬁnd any data
in literature regarding the phytochemical or pharmacological properties
of this genus. The scarcity of scientiﬁc information on the therapeutic
activity ofD. bicolorhinders its full utilization in evidence based comple-
mentary medicine and as a source of anti-infective agents. Aiming to
tackle this problem, we evaluated the in vitro antimicrobial activity of
D. bicolor crude extracts obtained from various parts including leaves,
ﬂowers and rhizomes. Moreover, the cytotoxic activity of these extracts
on nine different cell lines was also evaluated.
2. Materials and methods
2.1. Plant material
D. bicolor leaves, ﬂowers and rhizomes were collected in April, 2011
from a botanical garden on Cairo–Alexandria road and were kindly
identiﬁed and authenticated by Mrs Therease Labib, Consultant of
Plant Taxonomy at the Ministry of Agriculture and Director of Orman
Botanical Garden, Giza, Egypt. Voucher specimens were deposited in
the herbarium of the Department of Pharmacognosy, Faculty of Phar-
macy, Ain Shams University (voucher specimen number IA-10411).
2.2. Preparation of D. bicolor extracts
Plant material (leaves, ﬂowers and rhizomes) were air-dried and
ground into coarse powder. Fifty grams from each powderwere extract-
ed with 80% methanol (Kuete et al., 2012) for 3 days at room tempera-
ture. Extracts were ﬁltered, evaporated under vacuum at 45 °C, then
lyophilized and kept in the refrigerator for further biological studies.
2.3. Chemicals and reagents
Solvents used in the study were of analytical grade. All microorgan-
isms and culturemedia for the antibacterial and antifungal screening as-
says were supplied by the Regional Center for Mycology and
Biotechnology (RCMB), Al-Azhar University, Nasr City, Cairo, Egypt. Clo-
trimazole, the antifungal standard drug, was obtained from Bayer
Health Care Pharmaceuticals, Germany. Gentamicin, the antibacterial
standard drug, was obtained from Memphis Co. for Pharmaceutical
and Chemical Industries, Cairo, Egypt. For the assessment of cytotoxicactivity, cell culture reagents were obtained from Lonza (Basel,
Switzerland). Cancer cell lines including HeLa (cervical cancer cell
line), DLD-1 (colorectal adenocarcinoma cell line), HCT 116 (colorectal
carcinoma), T47D (human ductal breast epithelial tumor cell line),
MCF-7 (breast cancer cell line), MDA-231 (breast cancer cell line),
K562 (human erythromyeloblastoid leukemia cell line) and Molt4
(human acute lymphoblastic leukemia cell line) were obtained from
the Graduate Institute of Natural Products, College of Pharmacy,
Kaohsiung Medical University, Kaohsiung 807, Taiwan. Mucosal mast
cell-derived rat basophilic leukemia (RBL-2H3) cell line was purchased
from the American Type Culture Collection line (Bioresource Collection
and Research Centre, Hsin-Chu, Taiwan). Dulbecco's modiﬁed Eagle's
minimal essential medium (DMEM) powder and 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained
from Sigma-Aldrich (St. Louis, MO, USA).
2.4. Antimicrobial activity
2.4.1. Microorganisms used in the antimicrobial assays
The antimicrobial activity of the tested extracts was assessed against
standard Gram-positive bacteria including Staphylococcus aureus
(RCMB 000108) and Bacillus subtilis (RCMB 000102) and Gram-
negative bacteria including Pseudomonas aeruginosa (RCMB 000104)
and Escherichia coli (RCMB 000107). The tested fungi included Aspergil-
lus fumigatus (RCMB 002007), Geotrichum candidum (RCMB 052009),
Candida albicans (RCMB 005008) and Syncephalastrum racemosum
(RCMB 005005). All microorganism cultures were obtained from the
Regional Center forMycology and Biotechnology (RCMB), Al-AzharUni-
versity, Nasr City, Cairo, Egypt.
2.4.2. Antibacterial activity
The antibacterial activity was evaluated in vitro using the agar well
diffusionmethod. Centrifuged pellets of bacteria from a 24 h old culture
containing approximately 104–106 CFU (colony forming unit) per mL
were spread on the surface of the nutrient agar (NaCl 0.5%, tryptone
1%, yeast extract 0.5%, agar 1%, 1000 mL of distilled water, pH 7.0)
which was autoclaved at 121 °C for at least 20 min then cooled down
to 45 °C, poured into Petri dishes and allowed to settle. After solidiﬁca-
tion, wells of 6 mm diameter were cut in themediumwith the help of a
sterile metallic borer. Extracts were prepared at a concentration of
10 mg/mL in dimethyl sulfoxide (DMSO). The tested samples (100 μL)
were loaded into the wells. DMSO was loaded as the negative control.
All plates were observed for a zone of inhibition at 37 °C for 24 h. The
activity was determined by measuring the diameter of the inhibition
zone (in mm). Each inhibition zone was measured three times by cali-
per to get an average value. The test was carried out three times for
each bacterium culture (Rahman et al., 2001). Gentamicin was used as
the positive control at a concentration of 30 μg/mL.
2.4.3. Antifungal activity
The tested samples were separately screened for their antifungal ac-
tivity in vitro against A. fumigatus, G. candidum, C. albicans and
S. racemosum using agar well diffusion method on Sabouraud dextrose
agar plates (Rathore et al., 2000). The fungi culturewas puriﬁed by a sin-
gle spore isolation technique (Choi et al., 1999). Sabouraud dextrose agar
plates were prepared using a homogeneous mixture of glucose–pep-
tone–agar (40:10:15) sterilized by autoclaving at 121 °C for 20 min.
The sterilized solution (25 mL) was poured in each sterilized Petri dish
in the laminar ﬂow and left for 20 min to form the solidiﬁed Sabouraud
dextrose agar plate. These plates were inverted and kept at 30 °C in the
incubator to remove moisture and to check for any contamination.
2.4.4. Antifungal assay
Fungal strainwas grown in 5mLSabouraud dextrose broth (glucose:
peptone; 40:10) for 3 to 4 days to achieve 105 CFU/mL cells. The fungal
culture (0.1 mL) was spread out uniformly on the Sabouraud dextrose
99I.M. Ayoub et al. / South African Journal of Botany 95 (2014) 97–101agar plates by a sterilized triangular folded glass rod. Plates were left for
5–10 min so that the culture was properly adsorbed on the surface of
Sabouraud dextrose agar plates. Small wells (4 mm × 2 mm) were cut
into the plates with the help of a well cutter and the bottom of the
wells was sealed with 0.8% soft agar to prevent the ﬂow of the tested
sample at the bottom of the well. The tested samples were prepared
in DMSO at a concentration of 10 mg/mL. Tested samples (100 μL)
were loaded into the wells. DMSO was loaded as the negative control.
The plates were incubated at 30 °C for 3 to 4 days and then examined
for the formation of the inhibition zone. Each inhibition zone was mea-
sured three times by a caliper to get an average value. The test was per-
formed three times for each fungus. Clotrimazole (30 μg/mL) was used
as the positive control (Rathore et al., 2000).
2.4.5. Determination of the minimum inhibitory concentration (MIC)
The agar plate method was used to determine the MIC of the tested
extracts. Nutrient agar (for bacteria) and Sabouraud dextrose agar (for
fungi) were heated in the autoclave for 25 min at 121 °C and allowed
to cool to 45 °C. Two-fold serial dilutions of each sample were added
to the medium immediately before it was poured into the Petri dishes.
DMSO was used as the negative control. The culture of each organism
in the nutrient broth (beef extract 5 g/L and peptone 10 g/L, pH =
7.0) for bacteria and Sabouraud dextrose broth for fungi was diluted
with sterile distilled water to 105–106 CFU/mL. A loop of each suspen-
sion was inoculated in the appropriate medium with the sample or
the control added. After inoculation, the plates were incubated at 37 °C
for 24 h for bacteria, and at 30 °C for three to four days for fungi. The
MIC was considered to be the lowest concentration that completely
inhibited the visible growth of amicroorganism compared with the con-
trol (Rahman et al., 2001). Each test was performed in duplicate. The an-
tibiotics gentamicin and clotrimazole were used as the positive controls.
2.5. Cytotoxicity studies
2.5.1. Cell culture
The cytotoxicity of D. bicolor aqueous methanolic extracts was ex-
amined on nine cancer cell lines including HeLa, DLD-1, HCT 116,
T47D, MCF-7, MDA-231, K562, Molt4 and RBL-2H3. Cells were main-
tained in DMEM supplemented with 10% heat-inactivated fetal bovine
serum(FBS), 1mMsodiumpyruvate, 2mM L-glutamine, 100U/mLpen-
icillin, and 100 μg/mL streptomycin. Cells were cultured in CellstarTable 1









Bacillus subtilis (RCMBf 000102) 25.3 ± 0.7 0.24 16.2 ± 0.
Staphylococcus aureus (RCMB
000108)
20.4 ± 0.9 1.95 14.1 ± 0.
Gram negative bacteria
Escherichia coli (RCMB 000107) 19.7 ± 0.6 3.9 15.7 ± 0.
Pseudomonas aeruginosa (RCMB
000104)
17.2 ± 0.3 15.62 12.2 ± 0.
Fungi
Aspergillus fumigatus (RCMB 002007) 22.1 ± 0.5 0.48 16.1 ± 0.
Candida albicans (RCMB 005008) 18.8 ± 0.1 7.8 10.2 ± 0.
Geotrichum candidum (RCMB 052009) 19.2 ± 0.4 1.95 12.4 ± 0.
Syncephalastrum racemosum (RCMB
005005)
16.3 ± 0.1 31.25 9.7 ± 0.3
a D. bicolor leaf extract.
b D. bicolor rhizomes extract.
c D. bicolor ﬂowers extract.
d Data are measured in triplicate (n = 3) and presented as means ± S.D., well diameter: 6.
e Gentamicin.
f Regional Centre of Mycology and Biotechnology, Al-Azhar University.
g Clotrimazole.(10 cm cell culture dishes) in a humidiﬁed chamber with 5% (v/v) CO2
in air at 37 °C. The cells were maintained asmonolayer culture by serial
subculturing. All experiments were carried out using cells in the loga-
rithmic growth phase.
2.5.2. Cytotoxicity assay
The sensitivity of human cancer cells to the tested D. bicolor aqueous
methanolic extracts was determined using the MTT assay (Marks et al.,
1992; Van de Loosdrecht et al., 1991). The assay depends on the fact
that MTT, a yellow colored compound, is converted by viable cells into
formazan, a purple derivative. Freshly trypsinized cell suspensions were
seeded at densities of 7000 cells per well (for HeLa, DLD-1, HCT 116,
T47D, MCF-7, MDA-231), 2 × 104 cells per well (for K562, RBL-2H3)
and 4 × 104 cells per well (for Molt4) in a 96-well culture plate and incu-
bated overnight. The tested extracts were dissolved in DMSO to form
stock solutions of 1 mg/mL. Cells were treated with various concentra-
tions of the tested samples (1, 10 and 100 μg/mL). The appropriate dilu-
tions of each extract were prepared in the culture medium and added
to the cells (the ﬁnal concentration of DMSOwas less than 0.2% in the cul-
ture well) and were incubated for 72 h at 37 °C under 5% (v/v) CO2. The
medium was removed from each well. A stock MTT solution (5 mg/mL)
was diluted 1:10 in culture medium and was added to the wells (100 μL
per well). Cells were then incubated for 4 h. The medium was removed
and the formed formazan crystalswere dissolved in DMSO and the absor-
bance was recorded at 550 nm. The assay was performed in triplicate for
each sample concentration. The % cell viability of three independent ex-
periments was calculated by the following formula:
% cell viability ¼ O:D of treated cells−O:D of culture medium
O:D of untreated cells−O:D of culture medium 100
where O.D = optical density.
Cytotoxicity was expressed as IC50 which is the concentration that re-
duces the absorbance value of the treated cells by 50% compared to the
control (untreated cell). Doxorubicin was used as the positive control.
2.6. Data analysis
Data were measured in triplicates (n = 3) and expressed as
means ± S.D. The 50% inhibitory concentration (IC50) was calculated













6 31.25 20.3 ± 0.7 1.95 29.1 ± 0.04 0.03
2 62.5 18.8 ± 0.5 7.8 25.1 ± 0.08 0.24
Gent.
3 31.25 17.4 ± 0.5 15.62 25.6 ± 0.04 0.12
3 125 14.3 ± 0.1 62.5 24.3 ± 0.08 0.24
Clot.g
2 31.25 18.2 ± 0.9 7.8 26.1 ± 0.01 0.12
8 250 14.4 ± 0.1 62.5 18.3 ± 0.01 3.9
6 125 15.4 ± 0.5 62.5 23.1 ± 0.03 0.48
500 13.1 ± 0.3 125 20.5 ± 0.02 0.97
0 mm (100 μL was tested).
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3.1. Antibacterial activity
MIC values are commonly used as the selectivity criterion in screen-
ing for new antimicrobials. A crude extract is considered to be promis-
ing with MIC below 100 μg/mL, meanwhile, a pure compound
showingMIC of 4 to 16 μg/mL is considered as a promising antimicrobial
agent with optimal value less than or equal to 1 μg/mL (Cos et al., 2006;
Gibbons, 2008). In general, the crude extracts of D. bicolor leaves,
ﬂowers and rhizomes inhibited the growth of all tested standard
Gram-positive and Gram-negative bacteria in the diffusion assay. The
leaf extract showed the most potent activity against S. aureus and
B. subtilis showing inhibition zones of 20.4 and 25.3 mm, respectively.
The MIC values ranged between 0.24 and 1.95 μg/mL against the tested
Gram-positive bacteria (Table 1). The leaf extract was also effective
against the tested Gram-negative bacteria showing inhibition zones of
17.2 and 19.7 mm against P. aeruginosa and E. coli, respectively, with
MIC values of 15.62 and 3.9 μg/mL. The aqueous methanolic extract of
the ﬂowers also showed promising antimicrobial activity with MIC
values ranging between 7.8 and 62.5 μg/mL against all tested bacteria.
Meanwhile, the rhizomes extract exhibited good activity against
S. aureus, B. subtilis and E. coli with MIC values ranging between 31.25
and 62.5 μg/mL whereas a moderate antimicrobial activity was ob-
served against P. aeruginosawith MIC value of 125 μg/mL.
3.2. Antifungal activity
The availability of safe antifungal agents is limited, thus the search
for new candidates from natural sources is mandatory. The promising
antibacterial activities exhibited byD. bicolor crude extracts, encouraged
us to assess their antifungal activities. In general, all extracts were effec-
tive against all tested fungi (Table 1). The aqueousmethanolic extract of
the leaves exhibited the most potent antifungal activity with zones of
inhibition approaching that of clotrimazole (at the used concentrations)
and MIC values ranging between 0.48 and 31.25 μg/mL. The inhibition
zone of the leaf extract (10 mg/mL) against C. albicans was 18.8 mm,
while the inhibition zone of the well-known antifungal agent, clotrima-
zole (30 μg/mL), was 18.3mm. Furthermore, theMIC value of the leaves
extract against C. albicans was 7.8 μg/mL which was found to be twice
that of clotrimazole (3.9 μg/mL). These data suggest that the
anticandidal activity of the leaf extract is very promising and compara-
ble to that of clotrimazole. The aqueous methanolic extract of the
ﬂowers showed the most potent activity against A. fumigatus (MIC
7.8 μg/mL). However, a moderate activity was observed against
S. racemosum (MIC 125 μg/mL). On the other hand, the rhizomes exhib-
ited amoderate to weak antifungal activity withMIC values ranging be-
tween 31.25 and 500 μg/mL against the tested fungi. The results
obtained in this study were consistent with the reports on the antimi-
crobial activity of the crude alcoholic extracts of different species be-
longing to family Iridaceae (Al-Khateeb et al., 2013; Ifesan et al., 2010;
Ramtin et al., 2013; Rani and Nair, 2011).
3.3. Cytotoxicity
MTT assay was used to evaluate the cytotoxic activity of the crude
extracts of D. bicolor leaves, ﬂowers and rhizomes on nine different can-
cer cell lines, namely HeLa, DLD-1, HCT 116, T47D, MCF-7, MDA-231,
K562, Molt4 and RBL-2H3. None of the D. bicolor extracts exhibited cy-
totoxicity against all cancer cell lines after 72 h treatment, compared
to the control. The IC50 values were found to be greater than
100 μg/mL for all extracts against the tested cancer cell lines. Mean-
while, doxorubicin the positive control, exhibited IC50 values ranging
between 0.001 and 0.20 μg/ml. Despite the antimicrobial activity exhib-
ited by the crude extracts ofD. bicolor leaves,ﬂowers and rhizomes, they
were ineffective as cytotoxic agents at doses up to 100 μg/mL. Thereported antimicrobial activity with the lack of measurable cytotoxicity
indicates that D. bicolor extracts act as antimicrobial agents through a
mechanism other than cytotoxicity.
4. Conclusion
Theworldwide increase in the antimicrobial drug resistance and the
promising antimicrobial activity of D. bicolor extracts are encouraging
factors to investigate the possibility of their utilization as a future source
for antimicrobial drug candidates. It is obvious that the crude extracts of
D. bicolor leaves, ﬂowers and rhizomes possess promising broad spec-
trum antimicrobial activity against certain Gram-positive and Gram-
negative bacteria as well as all fungi, especially the leaf extract which
exerted the most potent activity. These ﬁndings provide scientiﬁc evi-
dence to support the ethno-medicinal uses of Dietes sp. for the treat-
ment of diarrhea and dysentery. Thus, these ﬁndings merits further
studies to isolate and identify the bioactive compounds responsible for
the observed antimicrobial activities. The lack of measurable cytotoxic-
ity against all the nine tested cancer cell lines, suggests the use of
D. bicolor as a potential natural antibacterial and antifungal drug with
a good safety proﬁle.
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